Related references
Note: Only part of the references are listed.Human and mouse hepatocellular adenoma and carcinoma display similar tumorigenesis pathway alterations
Jessica Zucman-Rossi
JOURNAL OF HEPATOLOGY (2008)
Hepatology - Genetic alterations of Wnt signaling pathway-associated genes in hepatocellular carcinoma
Young-Dae Kim et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2008)
Phospho-regulation of β-catenin adhesion and signaling functions
Rebecca Leadem Daugherty et al.
PHYSIOLOGY (2007)
WNT signaling pathway and stem cell signaling network
Masuko Katoh et al.
CLINICAL CANCER RESEARCH (2007)
Cholestasis is a marker for hepatocellular carcinomas displaying β-catenin mutations
V. Audard et al.
JOURNAL OF PATHOLOGY (2007)
WNT/β-catenin signaling in liver health and disease
Michael D. Thompson et al.
HEPATOLOGY (2007)
Differential effects of inactivated Axin1 and activated β-catenin mutations in human hepatocellular carcinomas
J. Zucman-Rossi et al.
ONCOGENE (2007)
Characterization of an antibody that can detect the Kai1/CD82 murine metastasis suppressor
MC Custer et al.
PROSTATE (2006)
Regulation of Wnt signaling by protein-protein interaction and post-translational modifications
A Kikuchi et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2006)
Genetics of hepatocellular tumors
P. Laurent-Puig et al.
ONCOGENE (2006)
Dysregulation of growth factor signaling in human hepatocellular carcinoma
K. Breuhahn et al.
ONCOGENE (2006)
Activation of the canonical Wnt/β-catenin pathway confers growth advantages in c-Myc/E2F1 transgenic mouse model of liver cancer
DF Calvisi et al.
JOURNAL OF HEPATOLOGY (2005)
Hepatocellular carcinoma: Molecular pathways and new therapeutic targets
LR Roberts et al.
SEMINARS IN LIVER DISEASE (2005)
Overview of the molecular biology of hepatocellular neoplasms and hepatoblastomas of the mouse liver
Y Kim et al.
TOXICOLOGIC PATHOLOGY (2005)
Activation of β-catenin provides proliferative and invasive advantages in c-myc/TGF-α hepatocarcinogenesis promoted by phenobarbital
DF Calvisi et al.
CARCINOGENESIS (2004)
Disruption of β-catenin pathway or genomic instability define two distinct categories of liver cancer in transgenic mice
DF Calvisi et al.
GASTROENTEROLOGY (2004)
Diagnostic utility of the HepPar1 antibody to differentiate hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration samples
MT Siddiqui et al.
CANCER CYTOPATHOLOGY (2002)
Selective pressure during tumor promotion by phenobarbital leads to clonal outgrowth of β-catenin-mutated mouse liver tumors
H Aydinlik et al.
ONCOGENE (2001)
Share Paper
